Neighbourly Pharmacy (NBLY) Stock Forecast & Price Target

C$18.60 +0.06 (+0.32%)

(As of 03/21/2024)

Neighbourly Pharmacy - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 3 Analyst Ratings

Sell
0

Hold
3

Buy
0

Based on 3 Wall Street analysts who have issued ratings for Neighbourly Pharmacy in the last 12 months, the stock has a consensus rating of "Hold." Out of the 3 analysts, 3 have given a hold rating for NBLY.

Consensus Price Target

C$18.90
1.61% Upside

According to the 3 analysts' twelve-month price targets for Neighbourly Pharmacy, the average price target is C$18.90. The highest price target for NBLY is C$20.50, while the lowest price target for NBLY is C$18.50. The average price target represents a forecasted upside of 1.61% from the current price of C$18.60.

Get the Latest News and Ratings for NBLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Neighbourly Pharmacy and its competitors.

NBLY Analyst Ratings Over Time

Type	Current Forecast 11/19/23 to 11/18/24	1 Month Ago 10/20/23 to 10/19/24	3 Months Ago 8/21/23 to 8/20/24	1 Year Ago 11/19/22 to 11/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	3 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	C$18.90	C$18.90	C$18.90	C$23.07
Forecasted Upside	1.61% Upside	1.61% Upside	1.61% Upside	29.98% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Tech funds are hemorrhaging cash: Sell this stock now (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

NBLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NBLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Neighbourly Pharmacy Stock vs. The Competition

Type	Neighbourly Pharmacy	Medical Companies
Consensus Rating Score	2.00	2.80
Consensus Rating	Hold	Moderate Buy
News Sentiment Rating	Neutral News See Recent NBLY News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
2/14/2024	Desjardins 2 of 5 stars	Lower Target	Hold	C$20.00 ➝ C$18.50	+0.71%
2/14/2024	TD Securities 4 of 5 stars	Downgrade	Outperform ➝ Sector Perform	C$28.00 ➝ C$18.50	+0.71%
1/15/2024	National Bankshares 1 of 5 stars	Lower Target	Sector Perform ➝ Tender	C$20.50 ➝ C$18.50	+1.54%
12/19/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Market Perform	C$18.50 ➝ C$20.50	+36.76%
12/19/2023	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		C$20.50 ➝ C$18.50	+23.42%
8/2/2023	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	C$24.50 ➝ C$24.00	+39.45%
7/13/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	C$34.00 ➝ C$28.00	+77.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:41 AM ET.

NBLY Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Neighbourly Pharmacy is C$18.90, with a high forecast of C$20.50 and a low forecast of C$18.50.
: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares.
: According to analysts, Neighbourly Pharmacy's stock has a predicted upside of 1.61% based on their 12-month stock forecasts.
: Analysts like Neighbourly Pharmacy less than other "medical" companies. The consensus rating for Neighbourly Pharmacy is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NBLY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Tech funds are hemorrhaging cash: Sell this stock now (Ad)

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

This page (TSE:NBLY) was last updated on 11/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neighbourly Pharmacy (NBLY) Stock Forecast & Price Target